Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Pascal Deschatelets
Age : 51
Public asset : 57,531,698 USD
Country of residence : Unknown
Linked companies : Apellis Pharmaceuticals, Inc.

Biography of Pascal Deschatelets 
Pascal Deschatelets is an entrepreneur who founded Apellis Pharmaceuticals, Inc., Potentia Pharmaceuticals, Inc., Revon Systems, Inc. and Syntetica Fine Chemicals. Presently, he holds the position of Chief Scientific Officer at Apellis Pharmaceuticals, Inc. He is also on the board of Revon Systems, Inc. Pascal Deschatelets previously held the position of Chief Operating Officer for Potentia Pharmaceuticals, Inc. He received a doctorate from the University of Montréal.


Current positions of Pascal Deschatelets 
Holdings of Pascal Deschatelets 
Pascal Deschatelets : Personal Network 
Most Read News 
09/28Buffett's Berkshire Hathaway buys 5.99 million more Occidental shares
RE
09/26Unilever's soap opera: M&A, Nelson Peltz, CEO to retire
RE
09/20JPMorgan CEO Dimon to warn Congress of economic 'storm clouds' -testimony
RE
09/26Twitter to interview Elon Musk, known for combative testimony
RE
09/21Trump ally Barrack's trial on foreign agent charges moves to opening statements
RE
09/29The long, winding road to Volkswagen's Porsche IPO
RE
09/20Palihapitiya to wind down two blank-check firms as choppy markets deter valuations
RE
09/21Bloomberg to spend $85 million against U.S. plastic, petrochem buildout
RE
09/28Elon Musk seeks to narrow SEC consent decree, end pre-approval of tweets
RE
09/21Samsung Elec's Lee says SoftBank's Son expected to visit Seoul -media
RE
More news


© 2022 People and Ownership :   
Pascal Deschatelets : Connections 


Latest news about Pascal Deschatelets 
09/12Insider Sell: Apellis Pharmaceuticals
MT
09/07Transcript : Apellis Pharmaceuticals, Inc. Presents at Citi's 17th Annual BioPharma Conference, Sep-07-2022 01:00 PM
CI
06/09Insider Sell: Apellis Pharmaceuticals
MT
05/03Insider Sell: Apellis Pharmaceuticals
MT
2021Transcript : Apellis Pharmaceuticals, Inc. - Special Call
CI
More news